Trial
NCT00216762
Safety Study of Rituximab (Rituxan®) in Chronic Urticaria
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Johns Hopkins University
Collaborators
Genentech, Inc.
Condition
Urticaria
Intervention
Rituximab
Why stopped
Full Clinical Hold
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-09-02